← Leaderboards
Anastasios Georgakopoulos
Icahn School Of Medicine At Mount Sinai
$4,577,985
Attributed
$7,480,156
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,480,156 · 4
By mechanism
R01$4,969,397 · 1
P50$1,675,814 · 2
R56$834,945 · 1
Top collaborators
- Nikolaos Robakis11 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Nikolaos Robakis$22,366,852
- Jeffrey Ohmann Bush$16,044,315
- Costica Aloman$2,480,715
- Yonejung Yoon$854,037
- Priti Balchandani$9,509,106
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMediatingProteinsPlayLinkFamilial Alzheimer DiseaseSignal TransductionNeuronsLigandsAdultNerve DegenerationS DiseaseAngiogenesisAffectEphrin B ReceptorProteolytic ProcessingComplexMetabolicAtrophicEndothelial CellsDensityBlood VesselsBrainRepaired
Grant awards (18)
Impairment of Ischemia-induced Vascular Functions by PS1 FAD Mutants$572,810
R01 · FY2025 · NS · contact PI
Impairment of Ischemia-induced Vascular Functions by PS1 FAD Mutants$684,839
R01 · FY2024 · NS · contact PI
Presenilin1/gamma-secretase regulate the VEGFA/VEGFR2 brain angiogenesis inhibited by FAD mutants.$834,945
R56 · FY2023 · AG
Impairment of ischemia-induced vascular functions by PS1 FAD mutants$646,658
R01 · FY2023 · NS · contact PI
Impairment of ischemia-induced vascular functions by PS1 FAD mutants$605,083
R01 · FY2022 · NS · contact PI
Impairment of ischemia-induced vascular functions by PS1 FAD mutants$606,710
R01 · FY2021 · NS · contact PI
Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and AD$370,781
R01 · FY2019 · NS · contact PI
Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and AD$370,781
R01 · FY2018 · NS · contact PI
Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and AD$370,781
R01 · FY2017 · NS · contact PI
Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and AD$370,781
R01 · FY2016 · NS · contact PI
Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and AD$370,173
R01 · FY2015 · NS · contact PI
ROLE OF PS1/Y-SECRETASE IN THE ANGIOGENIC PROPERTIES OF EPHRINB/EphB$220,423
P50 · FY2014 · AG · contact PI
ROLE OF PS1/Y-SECRETASE IN THE ANGIOGENIC PROPERTIES OF EPHRINB/EphB$224,101
P50 · FY2013 · AG · contact PI
ROLE OF PS1/Y-SECRETASE IN THE ANGIOGENIC PROPERTIES OF EPHRINB/EphB$262,132
P50 · FY2012 · AG · contact PI
ROLE OF PS1/Y-SECRETASE IN THE ANGIOGENIC PROPERTIES OF EPHRINB/EphB$250,788
P50 · FY2011 · AG · contact PI
ROLE OF PS1/Y-SECRETASE IN THE ANGIOGENIC PROPERTIES OF EPHRINB/EphB$235,966
P50 · FY2010 · AG · contact PI
PS1 REGULATES CLEAVAGE OF EPHRIN B LIGAND AND EPHB RECEPTOR$244,472
P50 · FY2009 · AG · contact PI
PS1 REGULATES CLEAVAGE OF EPHRIN B LIGAND AND EPHB RECEPTOR$237,932
P50 · FY2008 · AG · contact PI